HCID 86624407、化合物 → HCID 68420239、化合物
反応式
[N:1]([C@@H:4]([C:14]1[CH:15]=[N:16][C:17]([O:20][CH3:21])=[N:18][CH:19]=1)[CH2:5][O:6][Si:7]([C:10]([CH3:13])([CH3:12])[CH3:11])([CH3:9])[CH3:8])=[N+]=[N-]>C(OCC)(=O)C.[Pd]>[Si:7]([O:6][CH2:5][C@H:4]([C:14]1[CH:19]=[N:18][C:17]([O:20][CH3:21])=[N:16][CH:15]=1)[NH2:1])([C:10]([CH3:13])([CH3:12])[CH3:11])([CH3:9])[CH3:8]参加物
4
実験手順
A mixture of (S)-5-(1-azido-2-(tert-butyldimethylsilyloxy)ethyl)-2-methoxypyrimidine (11.7 g, 37.7 mmol) in ethyl acetate (300 mL), and 10% Pd—C (70 mg) was stirred under H2 (1 atm) overnight. The catalyst was filtered off and the filtrate was concentrated to yield a light oil. The residue was purified by silica gel chromatography (0-50% MeOH/EtOAc) to afford a colorless oil.
後処理
- filtrationThe catalyst was filtered off
- concentrationthe filtrate was concentrated
- customto yield a light oil
- customThe residue was purified by silica gel chromatography (0-50% MeOH/EtOAc)
- customto afford a colorless oil
出典と根拠
- ORDレコード
- ord-7a765d485faa42c595e5aad4e8be7123
- 出典データセット
- uspto-grants-2011_12
- 特許番号
- US08076345B2
反応ノート
読み込み中…